Gene expression of non-homologous end-joining pathways in the prognosis of ovarian cancer

Ovarian cancer is the deadliest gynecologic malignancy in women, with a 46% five-year overall survival rate. The objective of the study was to investigate the effects of non-homologous end-joining (NHEJ) genes on clinical outcomes of ovarian cancer patients. To determine if these genes act as progno...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavi, Ethan S., Lin, Z. Ping, Ratner, Elena S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558711/
https://www.ncbi.nlm.nih.gov/pubmed/37810216
http://dx.doi.org/10.1016/j.isci.2023.107934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558711/
https://www.ncbi.nlm.nih.gov/pubmed/37810216
http://dx.doi.org/10.1016/j.isci.2023.107934

Ejemplares similares